Skip to main content
. 2020 Jan 28;11(4):322–346. doi: 10.18632/oncotarget.27340

Figure 2. Immunohistochemistry of glioblastoma.

Figure 2

(A–D) Giant cell glioblastoma; (E–F) Small cell glioblastoma). (A) CD117+ cells in vessels (Genemed Ab); (B) CD117+ cells in vessels (Diagnostic BioSystems Ab); (C) CD117+ cells in glial scar (Genemed Ab); (D) CD117+ (Diagnostic BioSystems Ab) cells among tumor cells; (E) NG2+ cells in vessels; (F) NG2+ cells among tumor cells and in vessels. Antibodies are detailed in the Supplementary Materials. All slides at 200×. CD117+ cells and NG2+ cells are stained brown.